Want to join the conversation?
For FY17, $PH expects total sales to be in the range of negative 1.5% to positive 2.1% as compared to the prior year. Sales are divided as 48% in 1H17 and 52% in 2H16, which is a normal distribution of a split in a year for $PH. This forecast excludes any acquisition and divestitures that might close during FY17, the company said.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)